Press Releases
CD Genomics Announces MicroCollect™ FDA&CE Certificated Virus Collection Swab Kits for SARS-CoV-2 Detection
SHIRLEY, NY – Jul 13, 2020 - CD Genomics, an internationally leading provider of microbial testing services, microbial genomics services, and integrated bioinformatics services for hospitals, food, diagnostics, pharma, agriculture, biotechnology, and research institutes, announces advanced virus collection kit for SARS-CoV-2 detection.
"CD Genomics is proud to produce high-quality, reliable tests with 100% specificity that provide patients with results they can trust as we continue to learn more about COVID-19," said chief executive officer, "We are unwavering in our belief that every test is a life."
The Virus Collection Kits are designed for the collection and short-time storage of total DNA/RNA in clinical specimens such as blood, saliva, stool, serum and body fluid, etc. The preservative will lyse the organisms and inactivate the viruses. The stored samples can be used for subsequent clinical experiments such as DNA/RNA extraction, PCR testing or sequencing. The kit is ideal for collecting specimens for coronavirus identification and downstream studies.
What are the characteristics of the CD virus collection kits at CD Genomics?
Absorbent material increases buccal cell concentrations to give high quality results
Stringent quality control
Packaged in a clean-room environment
Gamma irradiation ensures sterility
Tough, break-resistant tubes with secure, color-coded screw caps prevent leaking and exposure to contaminants.
Sampling can be done at home or other places without any special training
Highly suited for automation
Ideal for Coronavirus identification
MicroCollect™ FDA&CE Certificated Virus Collection Swab Kit is used for collection, transportation and storage of viral DNA/RNA samples. This product is suitable for the preservation of pharyngeal swabs, nasal swabs or tissue samples in specific parts after sampling. The stored samples can be used in subsequent clinical experiments such as nucleic acid extraction/purification, PCR experiments and next-generation sequencing (NGS).
“Early protection, early detection, early diagnosis, and early isolation are the key methods to prevent and control an infectious disease like the COVID-19. The detection of SARS-CoV-2 is very important for patient diagnosis. CD Genomics has been proven the high reliability of its products and is able to offer remarkable Kits for coronavirus detection.” said Dr. David.
About CD Genomics
As one of the world-leading genomics services company, CD Genomics innovates sequencing services, as well as genotyping, library construction, bioinformatics, aptamers, microarray, health diagnostics, mutagenesis analyses and others for the genomics industry.
Contact
Address: 45-1 Ramsey Road, Shirley, NY 11967, USA
Email: contact@cd-genomics.com
